Isolation and Characterization of Tumor Stem Cells from Melanoma Patients
黑色素瘤患者肿瘤干细胞的分离和表征
基本信息
- 批准号:8640894
- 负责人:
- 金额:$ 23.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectBiological AssayCandidate Disease GeneCell CountCell Culture TechniquesCell LineCell SeparationCell physiologyCell surfaceCellsCharacteristicsDataDevelopmentDimensionsDiseaseDistalEngraftmentEnvironmentEpidemicEpigenetic ProcessFrequenciesGene ExpressionGene Expression ProfileGene Expression ProfilingGenesGeneticGoalsHumanImmunophenotypingKnowledgeLaboratoriesMalignant NeoplasmsMedicalMelanoma CellMethodsMolecularMolecular ProfilingMusMutationNeoplasm MetastasisNeoplasm TransplantationNeoplasmsOrganPathogenesisPathway interactionsPatientsPhenotypePlant RootsPopulationPropertyRadioRegimenReporterReportingRepressionResistanceRoleSamplingSiteSkinSpeedStagingSurface AntigensTechnologyTestingTherapeuticTissuesTumor Stem CellsUnited StatesVisceralXenograft Modelbasecancer cellcancer therapydesignimprovedin vivoin vivo Modelmelanocytemelanomamolecular phenotypemouse modelneoplastic cellprotein expressionreconstitutionscreeningself-renewalsmall hairpin RNAstemstemnesstherapy designtumortumor growthtumorigenic
项目摘要
Project Summary
The rapid rise of melanoma, in the United States, in the absence of effective therapeutic regimens underscores
the urgency and importance of obtaining a deeper knowledge about pathogenesis of this disease. In this
project we propose that melanoma is driven by subpopulation of CD271 positive tumor initiating cells. Tumor
stem cells (TSCs) in other cancers were shown to be resistant to most conventional chemo and radio
therapies, to have the ability to self-renew and efficiently replenish the entire tumor cell population eliminated
after traditional medical regimens. Thus to design more successful cancer therapy one must isolate and study
the properties of respective TSCs. The primary goal of this proposal is to putatively isolate highly enriched
melanoma TSCs from broad spectrum of melanomas and to characterize their molecular profile. We will reach
this goal by designing and accomplishing following experimental tasks:
1. Identify and prospectively isolate melanoma TSC by CD271 and additional cell surface markers expression
using advanced Fluorescent Activated Cell Sorting and in-vivo tumor transplantation assays.
2. Characterize genetic and/or epigenetic alterations that lie at the root of CD271+ MTSC function by
performing global gene expression analysis of MTSCs using microarray and lentiviral reporter technologies;
confirm critical role of specific gene candidates in MTSC phenotype
3. Analyze MTSC's advanced tumorigenic properties in the environment that closely reflects natural
occurrence of this cancer in humans by characterizing invasive characteristics of MTSCs and a functional role
of CD271 in human skin reconstruct mouse model.
项目摘要
黑色素瘤在美国的迅速上升,在缺乏有效的治疗方案强调,
进一步认识本病发病机制的紧迫性和重要性。在这
我们的项目提出黑色素瘤是由CD 271阳性肿瘤起始细胞亚群驱动的。肿瘤
其他癌症中的干细胞(TSCs)对大多数常规化疗和放疗都有抵抗力,
治疗,有能力自我更新和有效地补充整个肿瘤细胞群消除
在传统的医疗方案之后。因此,为了设计更成功的癌症治疗方法,必须分离和研究
各自TSC的特性。该提案的主要目标是将高度浓缩的
从广谱黑色素瘤中分离黑色素瘤TSC并表征其分子谱。我们将达到
设计并完成了以下实验任务:
1.通过CD 271和其他细胞表面标志物表达识别和前瞻性分离黑色素瘤TSC
使用先进的荧光激活细胞分选和体内肿瘤移植试验。
2.通过以下方式表征位于CD 271 + MTSC功能根源的遗传和/或表观遗传改变
使用微阵列和慢病毒报告基因技术进行MTSC的整体基因表达分析;
证实特定候选基因在MTSC表型中的关键作用
3.分析MTSC在密切反映自然环境的环境中的高级致瘤性
通过描述MTSC的侵袭性特征和功能作用,
CD 271在人皮肤中的表达重建小鼠模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEXANDER D BOIKO其他文献
ALEXANDER D BOIKO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEXANDER D BOIKO', 18)}}的其他基金
Therapeutic Mechanism of CD47 Blockade in Suppressing Melanoma Metastasis
CD47阻断抑制黑色素瘤转移的治疗机制
- 批准号:
9888156 - 财政年份:2020
- 资助金额:
$ 23.88万 - 项目类别:
Therapeutic Mechanism of CD47 Blockade in Suppressing Melanoma Metastasis
CD47阻断抑制黑色素瘤转移的治疗机制
- 批准号:
10613354 - 财政年份:2020
- 资助金额:
$ 23.88万 - 项目类别:
Therapeutic Mechanism of CD47 Blockade in Suppressing Melanoma Metastasis
CD47阻断抑制黑色素瘤转移的治疗机制
- 批准号:
10330728 - 财政年份:2020
- 资助金额:
$ 23.88万 - 项目类别:
Isolation and Characterization of Tumor Stem Cells from Melanoma Patients
黑色素瘤患者肿瘤干细胞的分离和表征
- 批准号:
8616119 - 财政年份:2013
- 资助金额:
$ 23.88万 - 项目类别:
Isolation and Characterization of Tumor Stem Cells from Melanoma Patients
黑色素瘤患者肿瘤干细胞的分离和表征
- 批准号:
8830927 - 财政年份:2013
- 资助金额:
$ 23.88万 - 项目类别:
Isolation and Characterization of Tumor Stem Cells from Melanoma Patients
黑色素瘤患者肿瘤干细胞的分离和表征
- 批准号:
8317570 - 财政年份:2011
- 资助金额:
$ 23.88万 - 项目类别:
Isolation and Characterization of Tumor Stem Cells from Melanoma Patients
黑色素瘤患者肿瘤干细胞的分离和表征
- 批准号:
8189791 - 财政年份:2011
- 资助金额:
$ 23.88万 - 项目类别:
Isolation and Characterization of Melanoma Tumor Stem Cells
黑色素瘤肿瘤干细胞的分离和表征
- 批准号:
7565938 - 财政年份:2007
- 资助金额:
$ 23.88万 - 项目类别:
Isolation and Characterization of Melanoma Tumor Stem Cells
黑色素瘤肿瘤干细胞的分离和表征
- 批准号:
7329397 - 财政年份:2007
- 资助金额:
$ 23.88万 - 项目类别:
Isolation and Characterization of Melanoma Tumor Stem Cells
黑色素瘤肿瘤干细胞的分离和表征
- 批准号:
7743838 - 财政年份:2007
- 资助金额:
$ 23.88万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 23.88万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 23.88万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 23.88万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 23.88万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 23.88万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 23.88万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 23.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 23.88万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 23.88万 - 项目类别:
Postdoctoral Fellowships